Huaiwei B. Ding
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Low-Density Lipoprotein-Mimetic Nanoparticles Codelivering Self-Activated Cabazitaxel Prodrug and Verteporfin for Tumor Chemophotodynamic Therapy and Immune Activation.
Journal: Molecular pharmaceutics
Published: March 09, 2026
Design, synthesis, and evaluation of polycyclic pyridone derivatives as potent influenza inhibitors.
Design, synthesis, and evaluation of polycyclic pyridone derivatives as potent influenza inhibitors.
Journal: Bioorganic chemistry
Published: February 05, 2026
Towards prediction of placental site trophoblastic tumor by uterine artery pulsatility index.
Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 10, 2025
Corrigendum to "Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability" [Eur. J. Med. Chem. 276 (2024) 116646].
Journal: European journal of medicinal chemistry
Published: April 07, 2025
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
Journal: Cell death & disease
Published: March 28, 2025
Structural Studies on Mycobacterial NudC Reveal a Class of Zinc Independent NADH Pyrophosphatase.
Journal: Journal of molecular biology
Published: May 14, 2024
Design, synthesis and evaluation of carbamate-bridged amino acid prodrugs of cycloicaritin with improved antitumor activity, aqueous solubility and phase II metabolic stability.
Journal: European journal of medicinal chemistry
Published: March 11, 2024
Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitis.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 19, 2023
Exploration of 4-(1H-indol-3-yl)cyclohex-3-en-1-amine analogues as HDAC inhibitors: Design, synthesis, biological evaluation and modelling studies.
Journal: Bioorganic & medicinal chemistry letters
Published: May 02, 2022
DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis.
Journal: Biochemical pharmacology
Published: February 16, 2022
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: February 11, 2022
ZDQ-0620, a Novel Phosphatidylinositol 3-Kinase Inhibitor, Inhibits Colorectal Carcinoma Cell Proliferation and Suppresses Angiogenesis by Attenuating PI3K/AKT/mTOR Pathway.
Journal: Frontiers in oncology
Published: January 05, 2022
Last Updated: 09/26/2026